Northern Trust
TEVA icon

Northern Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Northern Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230M Buy
7,635,688
+2,035,692
+36% +$65.5M 0.03% 441
2025
Q4 		$175M Buy
5,599,996
+80,717
+1% +$1.99M 0.02% 542
2025
Q3 		$111M Buy
5,519,279
+66,639
+1% +$1.17M 0.01% 696
2025
Q2 		$91.4M Buy
5,452,640
+234,273
+4% +$3.78M 0.01% 751
2025
Q1 		$80.2M Buy
5,218,367
+12,007
+0.2% +$214K 0.01% 806
2024
Q4 		$115M Buy
5,206,360
+2,125,266
+69% +$38.7M 0.02% 657
2024
Q3 		$55.5M Sell
3,081,094
-400,781
-12% -$7.01M 0.01% 957
2024
Q2 		$56.6M Sell
3,481,875
-55,409
-2% -$853K 0.01% 929
2024
Q1 		$49.9M Sell
3,537,284
-50,038
-1% -$631K 0.01% 999
2023
Q4 		$37.5M Sell
3,587,322
-390,254
-10% -$3.64M 0.01% 1215
2023
Q3 		$40.6M Buy
3,977,576
+195,973
+5% +$1.82M 0.01% 1077
2023
Q2 		$28.5M Sell
3,781,603
-239,225
-6% -$1.94M 0.01% 1349
2023
Q1 		$35.6M Sell
4,020,828
-199,494
-5% -$1.97M 0.01% 1170
2022
Q4 		$38.5M Buy
4,220,322
+38,071
+0.9% +$332K 0.01% 1097
2022
Q3 		$33.8M Buy
4,182,251
+68,462
+2% +$605K 0.01% 1116
2022
Q2 		$30.9M Buy
4,113,789
+15,705
+0.4% +$137K 0.01% 1227
2022
Q1 		$38.5M Sell
4,098,084
-178,401
-4% -$1.49M 0.01% 1215
2021
Q4 		$34.3M Buy
4,276,485
+11,420
+0.3% +$103K 0.01% 1391
2021
Q3 		$41.5M Sell
4,265,065
-1,079,195
-20% -$10.1M 0.01% 1232
2021
Q2 		$52.9M Sell
5,344,260
-81,608
-2% -$864K 0.01% 1094
2021
Q1 		$62.6M Sell
5,425,868
-2,461,369
-31% -$28.2M 0.01% 946
2020
Q4 		$76.1M Sell
7,887,237
-68,217
-0.9% -$654K 0.01% 780
2020
Q3 		$71.7M Sell
7,955,454
-70,573
-0.9% -$747K 0.02% 701
2020
Q2 		$99M Buy
8,026,027
+8,155
+0.1% +$92.2K 0.02% 546
2020
Q1 		$72M Buy
8,017,872
+273,850
+4% +$2.81M 0.02% 596
2019
Q4 		$75.9M Buy
7,744,022
+69,034
+0.9% +$616K 0.02% 720
2019
Q3 		$52.8M Buy
7,674,988
+64,978
+0.9% +$498K 0.01% 930
2019
Q2 		$70.2M Buy
7,610,010
+846,650
+13% +$10.2M 0.02% 756
2019
Q1 		$106M Buy
6,763,360
+75,596
+1% +$1.33M 0.03% 538
2018
Q4 		$103M Buy
6,687,764
+175,173
+3% +$3.59M 0.03% 508
2018
Q3 		$140M Buy
6,512,591
+213,000
+3% +$4.94M 0.03% 451
2018
Q2 		$153M Buy
6,299,591
+583,439
+10% +$11.9M 0.04% 431
2018
Q1 		$97.7M Sell
5,716,152
-172,950
-3% -$3.38M 0.03% 571
2017
Q4 		$112M Sell
5,889,102
-200,992
-3% -$3.02M 0.03% 526
2017
Q3 		$107M Sell
6,090,094
-126,288
-2% -$2.84M 0.03% 528
2017
Q2 		$207M Sell
6,216,382
-19,614
-0.3% -$607K 0.06% 318
2017
Q1 		$200M Sell
6,235,996
-170,620
-3% -$5.82M 0.06% 318
2016
Q4 		$232M Buy
6,406,616
+5,180,670
+423% +$207M 0.07% 271
2016
Q3 		$56.4M Buy
1,225,946
+53,549
+5% +$2.79M 0.02% 778
2016
Q2 		$58.9M Sell
1,172,397
-75,860
-6% -$4.04M 0.02% 712
2016
Q1 		$68.5M Sell
1,248,257
-10,050
-0.8% -$590K 0.02% 621
2015
Q4 		$82.6M Sell
1,258,307
-92,008
-7% -$5.69M 0.03% 547
2015
Q3 		$76.2M Buy
1,350,315
+34,626
+3% +$2.25M 0.03% 579
2015
Q2 		$77.8M Buy
1,315,689
+24,312
+2% +$1.5M 0.02% 612
2015
Q1 		$80.5M Buy
1,291,377
+130,374
+11% +$7.58M 0.02% 604
2014
Q4 		$66.8M Sell
1,161,003
-92,591
-7% -$5.16M 0.02% 659
2014
Q3 		$67.4M Sell
1,253,594
-9,967
-0.8% -$528K 0.02% 623
2014
Q2 		$66.2M Sell
1,263,561
-10,778
-0.8% -$551K 0.02% 639
2014
Q1 		$67.3M Buy
1,274,339
+377,161
+42% +$17.4M 0.02% 646
2013
Q4 		$36M Sell
897,178
-160,268
-15% -$6.31M 0.01% 1030
2013
Q3 		$40M Sell
1,057,446
-222,485
-17% -$8.68M 0.01% 873
2013
Q2 		$50.2M Buy
+1,279,931
New +$49.8M 0.02% 664

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust's TEVA Position: Q1 2026 in Review

Northern Trust increased its Teva Pharmaceuticals (TEVA) stake by 36% in Q1 2026, buying an estimated $65.5M and bringing the position to 7,635,688 shares worth $230M. The position accounts for 0.03% of the portfolio, ranked #441.

Northern Trust first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $232M in Q4 2016. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Northern Trust held 7,635,688 shares of Teva Pharmaceuticals worth $230M as of Q1 2026.
  • Northern Trust bought 2,035,692 Teva Pharmaceuticals shares in Q1 2026, an estimated $65.5M.
  • Teva Pharmaceuticals made up 0.03% of Northern Trust's portfolio in Q1 2026, its #441 holding.
  • Northern Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Teva Pharmaceuticals position peaked at $232M in Q4 2016.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.